Mary Ann Jordan

18.7k total citations · 5 hit papers
115 papers, 15.3k citations indexed

About

Mary Ann Jordan is a scholar working on Cell Biology, Molecular Biology and Oncology. According to data from OpenAlex, Mary Ann Jordan has authored 115 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Cell Biology, 76 papers in Molecular Biology and 63 papers in Oncology. Recurrent topics in Mary Ann Jordan's work include Microtubule and mitosis dynamics (101 papers), Cancer Treatment and Pharmacology (58 papers) and 14-3-3 protein interactions (42 papers). Mary Ann Jordan is often cited by papers focused on Microtubule and mitosis dynamics (101 papers), Cancer Treatment and Pharmacology (58 papers) and 14-3-3 protein interactions (42 papers). Mary Ann Jordan collaborates with scholars based in United States, France and India. Mary Ann Jordan's co-authors include Leslie Wilson, Charles Dumontet, Douglas Thrower, L Wilson, Kathy Kamath, Robert Toso, Patricia Wadsworth, Leslie Wilson, Dulal Panda and W. Brent Derry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature reviews. Cancer.

In The Last Decade

Mary Ann Jordan

115 papers receiving 14.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microtubules as a target for anticancer drugs

2004 3.6k citations Mary Ann Jordan, Leslie Wilson profile →
Microtubule-binding agents: a dynamic field of cancer therapeutics

2010 1.4k citations Mary Ann Jordan et al. profile →
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.

1993 914 citations Mary Ann Jordan, Douglas Thrower et al. profile →
Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin

2005 590 citations Mary Ann Jordan PubMed profile →
Microtubules and actin filaments: dynamic targets for cancer chemotherapy

1998 530 citations Mary Ann Jordan, Leslie Wilson profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Ann Jordan United States	56	8.6k	6.2k	6.0k	2.7k	1.1k	115	15.3k
Leslie Wilson United States	68	9.8k 1.1×	7.1k 1.2×	4.7k 0.8×	2.4k 0.9×	1.0k 0.9×	189	16.6k
Susan Band Horwitz United States	78	10.9k 1.3×	5.8k 0.9×	12.1k 2.0×	3.0k 1.1×	1.6k 1.4×	235	20.4k
Alexander Levitzki Israel	74	14.3k 1.7×	2.2k 0.4×	5.9k 1.0×	1.7k 0.6×	723 0.7×	328	22.3k
M.E.M. Noble United Kingdom	63	9.9k 1.2×	2.9k 0.5×	2.9k 0.5×	1.5k 0.6×	388 0.4×	144	13.7k
Kevan M. Shokat United States	96	24.3k 2.8×	5.4k 0.9×	6.9k 1.2×	2.4k 0.9×	749 0.7×	305	34.2k
Jun O. Liu United States	64	8.9k 1.0×	1.9k 0.3×	2.7k 0.5×	1.3k 0.5×	621 0.6×	210	14.2k
Takao Yamori Japan	57	7.7k 0.9×	1.2k 0.2×	2.4k 0.4×	1.9k 0.7×	1.0k 1.0×	241	11.7k
Bruce C. Baguley New Zealand	64	9.1k 1.1×	1.1k 0.2×	4.3k 0.7×	3.8k 1.4×	803 0.7×	384	15.0k
Steven Grant United States	79	16.7k 1.9×	2.0k 0.3×	6.3k 1.0×	1.2k 0.4×	912 0.8×	451	23.2k
Craig M. Crews United States	90	27.8k 3.2×	1.9k 0.3×	11.2k 1.9×	2.5k 0.9×	869 0.8×	209	32.0k

Countries citing papers authored by Mary Ann Jordan

Since Specialization

Citations

This map shows the geographic impact of Mary Ann Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ann Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ann Jordan more than expected).

Fields of papers citing papers by Mary Ann Jordan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ann Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ann Jordan. The network helps show where Mary Ann Jordan may publish in the future.

Co-authorship network of co-authors of Mary Ann Jordan

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ann Jordan. A scholar is included among the top collaborators of Mary Ann Jordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ann Jordan. Mary Ann Jordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Azarenko, Olga, et al.. (2014). Antiproliferative Mechanism of Action of the Novel Taxane Cabazitaxel as Compared with the Parent Compound Docetaxel in MCF7 Breast Cancer Cells. Molecular Cancer Therapeutics. 13(8). 2092–2103. 72 indexed citations

Azarenko, Olga, Mary Ann Jordan, & Leslie Wilson. (2014). Erucin, the Major Isothiocyanate in Arugula (Eruca sativa), Inhibits Proliferation of MCF7 Tumor Cells by Suppressing Microtubule Dynamics. PLoS ONE. 9(6). e100599–e100599. 40 indexed citations

Rezania, Vahid, et al.. (2011). Modeling the effects of drug binding on the dynamic instability of microtubules. Physical Biology. 8(5). 56004–56004. 5 indexed citations

Kiris, Erkan, Donovan Ventimiglia, Mehmet Emre Sargin, et al.. (2011). Combinatorial Tau Pseudophosphorylation. Journal of Biological Chemistry. 286(16). 14257–14270. 31 indexed citations

Lopus, Manu, Emin Oroudjev, Leslie Wilson, et al.. (2010). Maytansine and Cellular Metabolites of Antibody-Maytansinoid Conjugates Strongly Suppress Microtubule Dynamics by Binding to Microtubules. Molecular Cancer Therapeutics. 9(10). 2689–2699. 169 indexed citations

Gan, Pei Pei, Joshua A. McCarroll, Sela T. Po’uha, et al.. (2010). Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of βIII-Tubulin. Molecular Cancer Therapeutics. 9(5). 1339–1348. 84 indexed citations

Lopus, Manu, Emin Oroudjev, Leslie Wilson, et al.. (2008). Maytansine derivatives and metabolites of antibody-maytansinoid conjugates inhibit microtubule polymerization and strongly suppress microtubule dynamics. Cancer Research. 68. 1406–1406. 1 indexed citations

LeBoeuf, Adria C., Sasha F. Levy, Arnab Bhattacharya, et al.. (2008). FTDP-17 Mutations in Tau Alter the Regulation of Microtubule Dynamics. Journal of Biological Chemistry. 283(52). 36406–36415. 38 indexed citations

Park, Ho-Yong, Sarah E. Aiyar, Ping Fan, et al.. (2007). Effects of Tetramethoxystilbene on Hormone-Resistant Breast Cancer Cells: Biological and Biochemical Mechanisms of Action. Cancer Research. 67(12). 5717–5726. 30 indexed citations

10.

Mikovits, Judy A., Lena Gerwick, Emin Oroudjev, et al.. (2007). Preclinical development of Aneustat (OMN54): a multifunctional multi-targeted natural product derivative with anti-tumor, anti-inflammatory and immuno-modulatory activity. Molecular Cancer Therapeutics. 6. 1 indexed citations

11.

Honoré, Stéphane, Kathy Kamath, Diane Braguer, et al.. (2004). Synergistic Suppression of Microtubule Dynamics by Discodermolide and Paclitaxel in Non-Small Cell Lung Carcinoma Cells. Cancer Research. 64(14). 4957–4964. 76 indexed citations

12.

Okouneva, Tatiana, Leslie Wilson, Bruce A. Littlefield, & Mary Ann Jordan. (2004). E7389 and ER-076349, synthetic halichondrin B analogs, suppress centromere dynamics in concert with mitotic block. Cancer Research. 64. 1255–1255. 2 indexed citations

13.

Honoré, Stéphane, Kathy Kamath, Diane Braguer, et al.. (2003). Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation.. PubMed. 2(12). 1303–11. 49 indexed citations

14.

Jordan, Mary Ann, Iwao Ojima, Mariagrazia Distefano, et al.. (2002). Effects of Novel Taxanes SB-T-1213 and IDN5109 on Tubulin Polymerization and Mitosis. Chemistry & Biology. 9(1). 93–101. 29 indexed citations

15.

Ngan, Vivian K., et al.. (2001). Mechanism of Mitotic Block and Inhibition of Cell Proliferation by the SemisyntheticVincaAlkaloids Vinorelbine and Its Newer Derivative Vinflunine. Molecular Pharmacology. 60(1). 225–232. 125 indexed citations

16.

Wagner, M M, Donald C. Paul, Chuan Shih, et al.. (1999). In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines. Cancer Chemotherapy and Pharmacology. 43(2). 115–125. 68 indexed citations

17.

Jordan, Mary Ann & Leslie Wilson. (1998). [22] Use of drugs to study role of microtubule assembly dynamics in living cells. Methods in enzymology on CD-ROM/Methods in enzymology. 298. 252–276. 67 indexed citations

18.

Panda, Dulal, Richard H. Himes, Richard E. Moore, Leslie Wilson, & Mary Ann Jordan. (1997). Mechanism of Action of the Unusually Potent Microtubule Inhibitor Cryptophycin 1. Biochemistry. 36(42). 12948–12953. 69 indexed citations

19.

Dhamodharan, R., Mary Ann Jordan, Douglas Thrower, L Wilson, & Patricia Wadsworth. (1995). Vinblastine suppresses dynamics of individual microtubules in living interphase cells.. Molecular Biology of the Cell. 6(9). 1215–1229. 145 indexed citations

20.

Panda, Dulal, et al.. (1995). Kinetic Stabilization of Microtubule Dynamics at Steady State in Vitro by Substoichiometric Concentrations of Tubulin-Colchicine Complex. Biochemistry. 34(31). 9921–9929. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact